Literature DB >> 22369746

Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy.

Li-Ping Chen1, Chuan Li, Chuan Wang, Tian-Fu Wen, Lu-Nan Yan, Bo Li.   

Abstract

BACKGROUND/AIMS: To identify risk factors related to postoperative recurrence for intrahepatic cholangiocarcinoma (ICC) patients with negative resection margin.
METHODOLOGY: A total of 64 ICC patients who underwent resection with negative margin at our center from 2002 to 2010 were recruited in the present study. All clinicopathological characteristics were assessed using univariate analyses. Independent risk factors were identified by Cox regression. Factors significant at a p<0.10 in the univariate analyses were involved in the multivariate analyses. The diagnostic accuracy of the identified risk factors was evaluated using receiver operating curve (ROC).
RESULTS: The overall 1-, 3- and 5-year recurrence-free survival rates for patients with ICC were 63%, 32% and 27%, respectively. The most common site of postoperative recurrence was the liver. Lymph node metastasis, perineural invasion and total tumor size greater than 5 cm showed prognostic power in multivariate analysis. The recurrence-free survival rates reduced with the increasing of the number of risk factor for patients with ICC.
CONCLUSIONS: This study suggested liver was the most common recurrence site and confirmed lymph node metastasis, perineural invasion and total tumor size greater than 5 cm may be associated with poor outcome for ICC patients with negative resection margin.

Entities:  

Mesh:

Year:  2012        PMID: 22369746     DOI: 10.5754/hge11820

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

Review 1.  Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma.

Authors:  Yuichi Sanada; Yujo Kawashita; Satomi Okada; Takashi Azuma; Shigetoshi Matsuo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

2.  Recurrence after operative management of intrahepatic cholangiocarcinoma.

Authors:  Omar Hyder; Ioannis Hatzaras; Georgios C Sotiropoulos; Andreas Paul; Sorin Alexandrescu; Hugo Marques; Carlo Pulitano; Eduardo Barroso; Bryan M Clary; Luca Aldrighetti; Cristina R Ferrone; Andrew X Zhu; Todd W Bauer; Dustin M Walters; Ryan Groeschl; T Clark Gamblin; J Wallis Marsh; Kevin T Nguyen; Ryan Turley; Irinel Popescu; Catherine Hubert; Stephanie Meyer; Michael A Choti; Jean-Francois Gigot; Gilles Mentha; Timothy M Pawlik
Journal:  Surgery       Date:  2013-03-15       Impact factor: 3.982

3.  Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database.

Authors:  Zeljka Jutric; W Cory Johnston; Helena M Hoen; Pippa H Newell; Maria A Cassera; Chet W Hammill; Ronald F Wolf; Paul D Hansen
Journal:  HPB (Oxford)       Date:  2016-01       Impact factor: 3.647

4.  A Transcriptomic Signature for Risk-Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma.

Authors:  Yuma Wada; Mitsuo Shimada; Kensuke Yamamura; Takeo Toshima; Jasjit K Banwait; Yuji Morine; Tetsuya Ikemoto; Yu Saito; Hideo Baba; Masaki Mori; Ajay Goel
Journal:  Hepatology       Date:  2021-06-15       Impact factor: 17.298

5.  Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors.

Authors:  Rui-Qing Liu; Shu-Jing Shen; Xiu-Feng Hu; Jie Liu; Li-Juan Chen; Xing-Ya Li
Journal:  Cancer Cell Int       Date:  2013-10-18       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.